- Q2 2023 Biovica International AB Earnings Call TranscriptDec 15, 2022€0.742 (+1.50%)Earnings
- Biovica International AB Market update FDA clearance TranscriptAug 18, 2022
- Q4 2022 Biovica International AB Earnings Call TranscriptJun 16, 2022€3.15 (+2.75%)Earnings
- Biovica International AB Corporate Analyst Meeting TranscriptMay 17, 2022
- Q3 2022 Biovica International AB Earnings Call TranscriptMar 15, 2022€2.62 (+7.74%)Earnings
- Q2 2022 Biovica International AB Earnings Call TranscriptDec 01, 2021€3.68 (+0.95%)Earnings
- Q1 2022 Biovica International AB Earnings Call TranscriptSep 02, 2021€5.85 (+6.29%)Earnings
- Biovica International AB CEO's Presentation Annual General Meeting 2021 - Pre-Recorded TranscriptAug 27, 2021
- Q4 2021 Biovica International AB Earnings Call TranscriptJun 18, 2021€4.48 (-0.22%)Earnings
- Biovica International AB Capital Markets Day (Virtual) TranscriptJun 09, 2021
- Q3 2021 Biovica International AB Earnings Call TranscriptMar 18, 2021€4.05 (+7.63%)Earnings
- Q2 2021 Biovica International AB Earnings Call TranscriptDec 08, 2020Earnings
Q2 2023 Biovica International AB Earnings Call Transcript
All right. Hello, everyone, and welcome to the Biovica Q2 interim report for the fiscal year of '22/'23.
Today, I have my colleagues, Cecilia Driving, our EVP and CFO; and Warren Cresswell, President of Biovica Americas, with me. And together, we will present the highlights of the report. And this is the agenda for the call. First of all, I'll make a very short Biovica introduction as I assume that people that are watching this call are familiar with the company. If you want more information, you can find that on our web page with a lot of in-depth presentations.
I'll go through the highlights. Cecilia will cover the financials, and Warren will give you an update about the U.S. status and the launch, et cetera. And at the end, we will have a summary and a Q&A session, and you can already now post your questions. And if you want to be anonymous, you can do that as well. You have to check box in the bottom. And we will also have our research analysts Dan Akschuti from Pareto and possibly Johan Unnerus from Redeye right into the call asking questions.
So just a short update of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)